You are here: Home » News-CM » Companies » Results
Business Standard

Bliss GVS Pharma consolidated net profit declines 25.28% in the September 2019 quarter

Capital Market 

Sales decline 8.02% to Rs 210.12 crore

Net profit of Bliss GVS Pharma declined 25.28% to Rs 30.98 crore in the quarter ended September 2019 as against Rs 41.46 crore during the previous quarter ended September 2018. Sales declined 8.02% to Rs 210.12 crore in the quarter ended September 2019 as against Rs 228.43 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales210.12228.43 -8 OPM %12.1218.18 -PBDT37.3165.13 -43 PBT33.8162.80 -46 NP30.9841.46 -25

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, November 12 2019. 16:33 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU